RecruitingNCT07211763

Comparison of Transcutaneous and Arterial Carbon Dioxide Sampling During Jet Ventilation, a Prospective. Study on Patients Undergoing Percutaneous Liver Tumour Radiofrequency Ablation

Transcutaneous Versus Arterial Carbon Dioxide Monitoring During Jet Ventilation


Sponsor

Sahlgrenska University Hospital

Enrollment

100 participants

Start Date

Apr 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

The study aims to compare the readings from two methods of monitoring carbon dioxide levels during jet ventilation when normal end-tidal monitoring is not possible. During jet ventilation it is technically not possible to monitor the levels of carbon dioxide in exhaled air as is the standard in preoperative care. We will compare transcutaneous (through the skin) monitoring to an arterial blood. sample. Both transcutaneous monitoring and arterial monitoring is currently used as the standard for this patient group at our institution. By collecting data prospectively we can evaluate if there. are discrepancies based on monitoring method. All patients will be treated per standard preoperative protocol and only patients consenting to participate will contribute data to the comparison and statistical analysis.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • adult patients undergoing percutaneous RF liver tumour ablation requiring jet ventilation

Exclusion Criteria1

  • disease or condition. not compatible with jet ventilation

Interventions

OTHERNo Interventions

No intervention, solely data collection


Locations(1)

Sahlgrenska University Hospital

Gothenburg, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07211763


Related Trials